Back to Bank of New York Mellon Corp Bank of New York Mellon Corp

ANVSANVS
Showing 8 of 21 quarters

Position history for Bank of New York Mellon CorpBank of New York Mellon Corp's holdings in ANNOVIS BIO INC

Bank of New York Mellon Corp holds 15,476 shares of ANVS (ANNOVIS BIO INC), worth $28,785 as of 2026-Q2.

Current Value

$28,785

Current Shares

15,476

Total Value Change

-$124,831

Total Shares Change

-3,583

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
15,476
0.0%
$28,7850.0%$1.86
0
2026-Q1
Decreased
15,476
-22.8%
$34,5110.0%$2.58
0
2025-Q4
Increased
20,058
+5.3%
$69,4010.0%$3.46
15
2025-Q3
Unchanged
19,058
0.0%
$39,4500.0%$2.04
0
2025-Q2
Unchanged
19,058
0.0%
$41,3560.0%$2.05
0
2025-Q1
Unchanged
19,058
0.0%
$28,5880.0%$1.65
0
2024-Q4
Decreased
19,058
-0.0%
$95,8610.0%$5.08
0
2024-Q3
Unchanged
19,059
0.0%
$153,6160.0%$8.10
0

Other major holders of ANVS: VOLORIDGE INVESTMENT MANAGEMENT, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., MARSHALL WACE, LLP, GEODE CAPITAL MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used